News | UAMS Winthrop P. Rockefeller Cancer Institute

Winthrop P. Rockefeller Cancer Institute: UAMS Performs First GammaTile Brain Surgery in Arkansas

LITTLE ROCK — Radiation oncologist Richard Crownover, M.D., Ph.D., and neurosurgeon Analiz Rodriguez, M.D., Ph.D., and their care team at the University of Arkansas for Medical Sciences (UAMS) have performed the state’s first application of GammaTile Therapy.

Read more View the Winthrop P. Rockefeller Cancer Institute Archive

For the Media

At UAMS, our Office of Communications & Marketing is a full-service news office, available 24 hours a day to respond to inquiries from members of the news media.

More News

Members of the UAMS proteomics team are Alan Tackett, Ph.D. (center front), and (l-r) Stephanie Byrum, Ph.D., Rick Edmondson, Ph.D., Aaron Storey, Ph.D., and Samuel Mackintosh, Ph.D.

Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team

LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…

UAMS Executive Vice Chancellor and College of Medicine Dean Susan Smyth, M.D., and UAMS Chancellor Cam Patterson, M.D., MBA, present Birrer (seated) with his commemorative medallion and inscribed wooden chair.

Michael Birrer, M.D., Ph.D., Invested in Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute

LITTLE ROCK — Michael Birrer, M.D., Ph.D., vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), was invested July 15 in the Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute. “Michael Birrer’s scholarly corpus is incredibly impressive, and the…

The NIH-funded Partners in Cancer Research Program is underway at the Winthrop P. Rockefeller Cancer Institute. Second-year medical students learning clinical and in-depth cancer research this summer include (l to r) Nadia Safar, Anna Bragg, Pamela Rosales, Payton Smith, Carl Ramponi, Faizan Cheema, Tom Kelly, M.D. (associate director of Cancer Research and Training), Angel Castro, Robert Kiss, Delanie Mack, Sangeetha Sonney and Claire Keisling. Matthew Newman is not pictured.

Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students

New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.

UAMS' Hui-Ming Chang, M.D., is leading the Phoenix Trial.

UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer

LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…

Want to read more stories like these?

View the Full List